Clinical Trial Update: Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis

View source ↗

Summary

An observational clinical trial evaluating carotid intima-media thickness and other atherogenic risk factors in patients with Cerebrotendinous Xanthomatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrotendinous Xanthomatosis

Snippet

Sponsor: Sheba Medical Center | Conditions: Cerebrotendinous Xanthomatosis (CTX) | Status: UNKNOWN